Ken Fisher’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Ken Fisher’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,121	Closed	–	–	1071
2022 Q3	$0	Sell	26,121 -2,000	-7%	–	﹤0.01%	998
2022 Q2	$0	Buy	28,121 +9,000	+47%	–	﹤0.01%	1010
2022 Q1	$0	Sell	19,121 -800	-4%	–	﹤0.01%	1030
2021 Q4	$0	Buy	19,921 +5,000	+34%	–	﹤0.01%	1017
2021 Q3	$0	Hold	14,921	–	–	﹤0.01%	980
2021 Q2	$0	Buy	14,921 +800	+6%	–	﹤0.01%	983
2021 Q1	$0	Buy	+14,121	New	–	﹤0.01%	988

Ken Fisher's SGYP Position: Q4 2022 in Review

Ken Fisher sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2022, closing a stake of 26,121 shares.

Ken Fisher first reported a position in SGYP in Q1 2021 and held it in 7 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold SGYP as of Q4 2022.

Ken Fisher reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2022 after selling out during the quarter.
Ken Fisher sold 26,121 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2022.
Ken Fisher first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2021 and held it in 7 quarters.
Ken Fisher's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q3 2022.
0 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2022.

Based on Fisher Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.